Estradiol (E2) concentration shapes the chromatin binding landscape of the estrogen receptor
Han, A. L.; Vinod Paul, K.; Rao, S.; Brechbuhl, H. M.; Sartorius, C. A.; Ramachandran, S.; Kabos, P.
Show abstract
How transcription factors (TF) selectively occupy a minute subset of their binding sites from a sizeable pool of putative sites in large mammalian genomes remains an important unanswered question. In part, nucleosomes help by creating formidable barriers to TF binding. TF concentration itself plays a crucial role in the competition between TFs and nucleosomes. In the case of nuclear receptors, the ligand adds another layer of complexity. Estrogen receptor alpha (ER) is a classic example where its main ligand estradiol (E2) can modulate ER binding on chromatin. Here we show a complete rewiring of ER binding as a function of E2 concentration. As E2 concentration increases by two orders of magnitude, ER levels decrease, and ER binding localizes to promoter-distal sites with strong ER motifs. At low E2 levels, abundant levels of ER are present in the nucleus, and ER binding occurs mostly at sites without an identifiable ER binding motif, potentially in cooperation with other TFs like STAT1. We propose that E2s effect on ER activity plays a major role in defining genome-wide ER binding profiles. Thus, variations in E2 concentrations in ER-positive breast tumors could be a significant factor driving heterogeneity in tumor phenotype, treatment response, and potentially drug resistance.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Intrinsically Disordered Regions Define Unique Protein Interaction Networks in CHD Family Remodelers 92%
- Histone H3K4me1 and H3K27ac play roles in nucleosome depletion and eRNA transcription, respectively, at enhancers 92%
- Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess 92%
Similar papers in this journal
- Higher-order chromatin organization defines Progesterone Receptor and PAX2 binding to regulate estradiol-primed endometrial cancer gene expression 96%
- Assessment of the Histone Mark-based Epigenomic Landscape in Human Myometrium at Term Pregnancy 94%
- CREB5 reprograms nuclear interactions to promote resistance to androgen receptor targeting therapies 93%
Similar papers in this journal
- Enhancer-driven local 3D chromatin domain folding modulates transcription in human mammary tumor cells 95%
- Glucocorticoid receptor activation induces gene-specific transcriptional memory and universally reversible changes in chromatin accessibility 93%
- ETV2 regulates PARP-1 binding protein to induce ER stress-mediated cell death in tuberin-deficient cells 91%
Similar papers in this journal
- Proliferative response of ERalpha-positive breast cancer cells to 10 uM enterolactone, and the associated alteration in the transcriptomic landscape. 95%
- Global transcriptome analysis reveals partial estrogen-like effects of karanjin in MCF-7 breast cancer cells 94%
- The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells. 92%
Similar papers in this journal
- Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 96%
- Estrogen-induced chromatin looping changes identify a subset of functional regulatory elements 95%
- Androgen receptor-mediated assisted loading of the glucocorticoid receptor modulates transcriptional responses in prostate cancer cells 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.